Transcript Slide 1
Quality and Safety in
Cancer Care
- the view from NHS QIS
Dr Frances Elliot & Hilary Davison
Chief Executive & Director of Guidance
and Standards
13 November 2009
www.nhshealthquality.org
Strategic context
Better Health, Better Care (2007)
Better Cancer Care (2008)
Living and Dying Well (2008)
Scottish Government Quality Strategy
(2009)
NHS QIS
Special Health Board established by the
Scottish Parliament in 2003
independent in our advice, assessments
and recommendations
Our vision and purpose
To lead the use of knowledge to promote
improvement in the quality of healthcare for
the people of Scotland
To deliver internationally recognised
excellence in quality improvement
What we do
We :
provide advice and guidance on effective clinical
practice, including setting standards
drive and support implementation of
improvements in quality
assess the performance of the NHS, reporting
and publishing the findings
Increasingly we do this as an integrated approach
Advice,
guidance and
standards
NHS QIS
Key Activity
Assessment,
measurement
and reporting
Assurance
Accountability
Implementation
and
improvement
support
Local
improvement
cycles
Implementation
Scottish Patient Safety Programme
New Directorate of Improvement and
Implementation Support
Networks
Clinical
Practice development
Clinical governance support
Changing Role
NHSScotland Quality Strategy
Healthcare Improvement Scotland
- a new body responsible for scrutinising
health services, including independent
healthcare
- retains and emphasises current functions of
NHS QIS in relation to quality improvement
The future
Integrated improvement programmes
Based on a robust analysis of the
evidence base
Will include a package of advice and
guidance for the service
The future
“Care bundle” approach with appropriate
improvement tools for the service to enable
implementation
Support from QIS and partners to make it
happen
Key quality indicators to enable local selfassessment and reporting on progress, with
proportionate external quality assurance
Quality Performance Indicator
Development Process
QPI Development Group Launch Meeting
(QPI development group)
Preparatory work
(QIS Knowledge Management Team)
Scoping
6-8 Months
(QPI development group, NHS QIS KMT)
Indicator Development
(QPI development group)
Cancer Taskforce Ratification of QPI
(Scottish Cancer Taskforce)
Consultation
(Regional Cancer Networks)
Finalisation
(NHS QIS, QPI development core group)
Publication
(NHS QIS)
’’s
QPI Development Group Launch
Meeting
Agree scope of preparatory work
Define criteria for QPI development
Inaugural meeting March 2010
Secretariat?
Preparatory Work (2 months)
NHS QIS Knowledge Management Team
Assess current guidance/evidence (AGREE)
Suggest scope for indicator development
Develop scope of indicators – background and need
Scoping (1 – 2 months)
NHS QIS knowledge management team and QPI
development group
Briefing paper
Overview of preparatory work
Summarise key information
Recommendations for draft QPI’s
Filter recommendations using agreed criteria/framework
Indicator Development Group
(1-2 months)
Review briefing paper and consider proposed
draft QPI’s
Create short list (?10)
Define numerators, denominators and
exclusions for each draft QPI
Draft Indicators Ratified
Draft QPI’s presented to SCTF for approval
prior to wider consultation
Consultation (1 – 3 months)
Consultation via regional networks
Local, regional and national
Who should we consult with?
For what purpose?
Level of user involvement?
Finalisation (2 months)
NHS QIS, QPI Development Group
Collate feedback from consultation
Refine QPI’s including numerators, denominators,
exclusions
Final ratification by SCTF
Publication and dissemination to Boards
Involvement
SCTF
Agree proposed QPI development process and final
sign off
NCQSG
Advise on tumour sites to be addressed and
sequencing
Involvement
Quality Performance Indicators Development Group
Short life group
clinical experts
Review information on topics referred from NCQSG
Draft QPI’s
Definitions
Involvement
NHS QIS
Review of evidence
Prepare briefing paper
Quality assurance, consistency checking, advice on
implementation
ISD
Alignment with national datasets
Ensure measurability
Input to definitions
For Consideration and Discussion
Ownership of the process
Ownership of the final output
How do we “badge”
How do we address tumour sites with little or
no evidence
Generation of the evidence base